Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of FKBP12 (unknown origin) measured for 6 hrs relative to control
Assay data:2 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of FKBP12 (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to FKBP12 (unknown origin)
Assay data:10 Active, 1 Activity ≤ 1 nM, 8 Activity ≤ 1 µM, 11 Tested
Protac activity at CRBN/FKBP12 in human Jurkat cells
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Induction of degradation of FKBP12 (unknown origin)
SPR Assay to Characterize Ternary Complex Formation with FKBP12 from US Patent US11603377: "MTORC1 modulators and uses thereof"
Assay data:45 Active, 63 Activity ≤ 1 µM, 63 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
SPR Assay to Determine Binding Affinity to FKBP12 from US Patent US11603377: "MTORC1 modulators and uses thereof"
Assay data:50 Active, 64 Activity ≤ 1 nM, 64 Activity ≤ 1 µM, 64 Tested
Binding affinity to FKBP12 (unknown origin) assessed as inhibition constant
Assay data:7 Active, 6 Activity ≤ 1 µM, 7 Tested
Inhibition of human full length recombinant mTOR/FKBP12 in presence of [gamma-33P]ATP incubated for 40 mins by radiometric scintillation counting analysis
PROTAC activity at CRBN/FKBP12 in human Jurkat cells assessed as induction of FKBP12 degradation incubated for 12 hrs by Western blot analysis
NanoBRET assay (FKBP12-NLuc) (FKBP1B)
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
NanoBRET assay (FKBP12-NLuc) (FKBP1A)
NanoBRET assay (FKBP51-NLuc) (FKBP1A)
Assay data:1 Tested
SummaryRelated BioAssays by Target
Competitive fluorescence polarization binding assay (FKBP1A)
Competitive fluorescence polarization binding assay (FKBP1B)
mTOR/FKBP12(h) Kinase panel
SPR Protocol to Measure Binding of a Compound to FKBP12 from US Patent US11059830: "Compounds that participate in cooperative binding and uses thereof"
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
Binding of Compounds to FKBP12 from US Patent US11059830: "Compounds that participate in cooperative binding and uses thereof"
Assay data:10 Active, 4 Activity ≤ 1 nM, 10 Activity ≤ 1 µM, 10 Tested
QSS Assist FP assay from US Patent US10538528: "5H-pyrrolo[2,3-D]pyrimidin-6(7H)-one derivative"
Assay data:35 Active, 16 Activity ≤ 1 nM, 35 Activity ≤ 1 µM, 35 Tested
PPlase Assay from US Patent US9505773: "Rapamycin analogues and their pharmaceutical use"
Assay data:18 Active, 18 Activity ≤ 1 µM, 18 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on